BioCentury
ARTICLE | Company News

Syn X in stroke deal with Janssen

January 11, 2001 8:00 AM UTC

Janssen, a division of Johnson & Johnson (JNJ), will evaluate human stroke markers from Syn X (CDNX:SYY) in its animal models of stroke and traumatic brain injury. SYY will receive research payments. ...